Repaglinide Sun (repaglinide)
Generic
- Region
- 🇪🇺 EU
- Active substance
- repaglinide
- Company
- Sun Pharmaceutical Industries B.V.
- Status
- Application withdrawn
- Therapeutic area
- Diabetes Mellitus, Type 2
- Designations
- Generic
- Application
- EMEA/H/C/001145
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Repaglinide Accord Withdrawn · Accord Healthcare S.L.U.
- 🇪🇺 Enyglid Authorised · KRKA tovarna zdravil d.d. Novo mesto
- 🇪🇺 Repaglinide Krka Authorised · KRKA tovarna zdravil d.d. Novo mesto
- 🇪🇺 Repaglinide Teva Authorised · Teva Pharma B.V.
- 🇪🇺 Prandin Authorised · Novo Nordisk A/S
- 🇪🇺 NovoNorm Authorised · Novo Nordisk A/S
Follow Repaglinide Sun
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.